Metformin Inhibits the Expression of Biomarkers of Fibrosis of EPCs In Vitro
Endothelial progenitor cells (EPCs) are a group of circulating cells with important functions in vascular repair and treatment of cardiovascular diseases. However, in patients with atrial fibrillation (AF), the number and function of EPCs reportedly are decreased. TGF-β is highly expressed in AF pat...
Main Authors: | Fei Han, Jie Shu, Shunjun Wang, Can-e Tang, Fanyan Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2019/9019648 |
Similar Items
-
BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer
by: Jie Shu, et al.
Published: (2019-01-01) -
EPC 4.0: The quest for reducing CAPEX in EPC projects
by: Wagner Reinhard F.
Published: (2020-07-01) -
Exosomes Containing LINC00636 Inhibit MAPK1 through the miR-450a-2-3p Overexpression in Human Pericardial Fluid and Improve Cardiac Fibrosis in Patients with Atrial Fibrillation
by: Langsha Liu, et al.
Published: (2021-01-01) -
Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ
by: Mehran Mesgari Abbasi, et al.
Published: (2016-01-01) -
Impairment of circulating endothelial progenitor cells (EPCs) in patients with glucocorticoid-induced avascular necrosis of the femoral head and changes of EPCs after glucocorticoid treatment in vitro
by: Peng Ding, et al.
Published: (2019-07-01)